These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 2143421)

  • 21. Inhibitors of ADP-ribosyl transferase suppress the mitogenic actions exerted by tumour promoters, but not those evoked by peptide mitogens, in primary neonatal rat hepatocytes.
    Romano F; Menapace L; Armato U
    Carcinogenesis; 1988 Dec; 9(12):2147-54. PubMed ID: 2973375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prooxidant-induced and spontaneous mitochondrial calcium release: inhibition by meta-iodo-benzylguanidine (MIBG), a substrate for mono (ADP-ribosylation).
    Richter C
    Free Radic Res Commun; 1990; 8(4-6):329-34. PubMed ID: 1693903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective probing of ADP-ribosylation reactions with oxidized 2'-deoxy-nicotinamide adenine dinucleotide.
    Alvarez-Gonzalez R; Moss J; Niedergang C; Althaus FR
    Biochemistry; 1988 Jul; 27(14):5378-83. PubMed ID: 3139033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly (ADP-ribose) metabolism in alkylated mouse L5178Y cells.
    Boyle JM
    Carcinogenesis; 1985 Jul; 6(7):1005-9. PubMed ID: 2990753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzamides can stimulate as well as inhibit the activity of nuclear ADP-ribosyltransferase.
    Jones J; Patel BN; Skidmore CJ
    Carcinogenesis; 1988 Nov; 9(11):2023-6. PubMed ID: 3141076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADP-ribosylation of highly purified rat brain mitochondria.
    Masmoudi A; Islam F; Mandel P
    J Neurochem; 1988 Jul; 51(1):188-93. PubMed ID: 2837535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amino acid specific ADP-ribosylation: specific NAD: arginine mono-ADP-ribosyltransferases associated with turkey erythrocyte nuclei and plasma membranes.
    West RE; Moss J
    Biochemistry; 1986 Dec; 25(24):8057-62. PubMed ID: 3099839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotinamide deficiency in human lymphocytes prevents the [3H]thymidine-induced adaptive response for the repair of X-ray-induced chromosomal damage.
    Wiencke JK
    Exp Cell Res; 1987 Aug; 171(2):518-23. PubMed ID: 2957224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.
    Winter S; Weller M
    Eur J Pharmacol; 2000 Jun; 398(2):177-83. PubMed ID: 10854828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase.
    Schraufstatter IU; Hyslop PA; Hinshaw DB; Spragg RG; Sklar LA; Cochrane CG
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4908-12. PubMed ID: 2941760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mono-ADP-ribosyltransferase activity during the execution phase of apoptosis prevents apoptotic body formation.
    Lodhi IJ; Clift RE; Omann GM; Sweeney JF; McMahon KK; Hinshaw DB
    Arch Biochem Biophys; 2001 Mar; 387(1):66-77. PubMed ID: 11368185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic mechanisms of two NAD:arginine ADP-ribosyltransferases: the soluble, salt-stimulated transferase from turkey erythrocytes and choleragen, a toxin from Vibrio cholerae.
    Osborne JC; Stanley SJ; Moss J
    Biochemistry; 1985 Sep; 24(19):5235-40. PubMed ID: 3935159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of glucocorticoid-induced cytolysis in sensitive human leukemic cells by an inhibitor of ADP-ribosylation.
    Meyer AS; Schlechte JA; Schmidt TJ
    Leuk Res; 1990; 14(10):909-14. PubMed ID: 2124310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production by Clostridium spiroforme of an iotalike toxin that possesses mono(ADP-ribosyl)transferase activity: identification of a novel class of ADP-ribosyltransferases.
    Simpson LL; Stiles BG; Zepeda H; Wilkins TD
    Infect Immun; 1989 Jan; 57(1):255-61. PubMed ID: 2521214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle.
    Li PL; Chen CL; Bortell R; Campbell WB
    Circ Res; 1999 Aug; 85(4):349-56. PubMed ID: 10455063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of inhibitors of poly(ADP-ribose) synthesis. Effects on nucleotide metabolism in cultured cells.
    Hunting DJ; Gowans BJ; Henderson JF
    Mol Pharmacol; 1985 Aug; 28(2):200-6. PubMed ID: 2991739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ADP-ribosyltransferase increases synthesis of Gs alpha in neuroblastoma x glioma hybrid cells and reverses iloprost-dependent heterologous loss of fluoride-sensitive adenylate cyclase.
    Donnelly LE; Boyd RS; Williams RJ; Kelly E; MacDermot J
    Biochem Pharmacol; 1995 Mar; 49(6):767-76. PubMed ID: 7535529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.
    Boulikas T
    Anticancer Res; 1992; 12(3):885-98. PubMed ID: 1535771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular determinants involved in the increase of damage-induced apoptosis and delay of secondary necrosis due to inhibition of mono(ADP-ribosyl)ation.
    Cerella C; Mearelli C; Ammendola S; De Nicola M; D'Alessio M; Magrini A; Bergamaschi A; Ghibelli L
    Ann N Y Acad Sci; 2006 Dec; 1090():50-8. PubMed ID: 17384246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-Aminobenzamide inhibits poly(ADP ribose) synthetase activity and induces phosphoenolpyruvate carboxykinase (GTP) in H4IIE hepatoma cells.
    Leverence RR; Beale EG; Granner DK
    Arch Biochem Biophys; 1988 Feb; 260(2):667-73. PubMed ID: 2829739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.